On October 2, 2024, MeCure Industries Plc, one of Nigeria’s leading pharmaceutical companies, announced the sale of a 10% equity stake to Zrosk Investment Management Ltd. This off-market transaction was conducted to meet the Nigerian Exchange Group’s (NGX) free float requirement for listed companies. In a statement regarding the investment, Arjun Udani, Co-CEO of MeCure …
